Official Title
Evaluation of Survival Prognostic Factors for Patients With Exocrine Pancreatic Cancer Resectable or Potentially Resectable : a Multicentre Prospective Cohort
Brief Title
Evaluation of Survival Prognostic Factors for Patients With Exocrine Pancreatic Cancer Resectable or Potentially Resectable
Protocol ID
NCT02818907
Lead Sponsor
Centre Hospitalier Universitaire de Besancon
Brief Summary
This study aims to collect clinical, biological and quality of life data from patients
with a borderline or resectable pancreatic cancer. It will collect information from the
date of diagnosis along the therapeutic care of the patients, and a 3-years follow-up
after the end of the treatment. The database will be updated at each patient's visit.
Biological samples will include: tumor, and plasma. Epidemiological data will also be
collected, whereas Quality of life will be assessed by the EORTC standard. The objectives
of this database are to identify new biomarkers (genomic, immunologic, and epidemiologic)
and promote high quality standard research protocol.
Study Period
-
Enrollment Count
290 participants
Eligibility Criteria
Inclusion Criteria:
- Patients with exocrine resectable pancreatic adenocarcinoma or potentially
resectable (that after neoadjuvant treatment are considered appropriate candidates
for resection)
- Histologically or cytologically documented diagnosis of exocrine pancreatic
adenocarcinoma
- Written informed consent obtained prior enrollment in the study
Exclusion Criteria:
- other types of pancreatic cancer, in particular endocrine tumor or acinar cells
- ampulloma
- metastatic disease
- other malignancy within the last 5 years, except for adequately treated carcinoma in
situ of the cervix or squamous carcinoma of the skin, or adequately controlled
limited basal cell skin cancer
- patient with any medical or psychiatric condition or disease which would make the
patient inappropriate for entry into this study
- patient under guardianship, curator or under the protection of justice.
Filters
Pancreatic Cancer
NA
COMPLETED
ADULT
OLDER_ADULT